Yusuke Sayama

Dr. Yusuke Sayama


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 February 2023 in Scientific Reports
Verified
Journal Article
Open access
PDF file
YSYusuke Sayama
Yusuke Sayama
MOMichiko Okamoto
Michiko Okamoto
MSMayuko Saito
Mayuko Saito
MSMariko Saito-Obata
Mariko Saito-Obata
RTRaita Tamaki
Raita Tamaki
HOHitoshi Oshitani
Hitoshi Oshitani
Four endemic human coronaviruses (HCoV), HCoV-229E, HCoV-NL63, HCoV-HKU1, and HCoV-OC43, are closely related to SARS-CoV-2. These coronaviruses are known to infect humans living in temperate areas, including children under 5 years old; however, the seroprevalence of four HCoVs among children in tropical areas, including the Philippines, remains unclear. This study aimed to assess the prevalence of antibodies against four HCoVs and to determine the reactivity and neutralization of these antibodies against SARS-CoV-2 among children in the Philippines. A total of 315 serum samples collected from 2015 to 2018, before the emergence of SARS-CoV-2, in Biliran island, Philippines, were tested for the presence of antibodies against four HCoVs and SARS-CoV-2 using recombinant spike ectodomain proteins by IgG-enzyme-linked immunosorbent assay (ELISA). Reactivity to and neutralization of SARS-CoV-2 were also investigated. The seroprevalence of the four HCoVs was 63.8% for HCoV-229E, 71.4% for HCoV-NL63, 76.5% for HCoV-HKU1, and 83.5% for HCoV-OC43 by ELISA. Age group analysis indicated that seropositivity to all HCoVs reached 80% by 2–3 years of age. While 69/315 (21.9%) of the samples showed reactive to SARS-CoV-2, almost no neutralization against SARS-CoV-2 was detected using neutralization assay. Reactivity of antibodies against SARS-CoV-2 spike protein obtained by ELISA may not correlate with neutralization capability.

16 May 2022 in IJID Regions
Verified
Journal Article
Open access
WAWilfredo E. Aure
Wilfredo E. Aure
YSYusuke Sayama
Yusuke Sayama
MSMariko Saito-Obata
Mariko Saito-Obata
NSNelia P. Salazar
Nelia P. Salazar
FMFedelino F. Malbas
Fedelino F. Malbas
HOHitoshi Oshitani
Hitoshi Oshitani
The aim of this study was to investigate the presence of Japanese encephalitis virus (JEV) in a rice-farming community in the Philippines and to determine its implications regarding the epidemiology of viral encephalitides in the Asia-Pacific Region. Mosquitoes were collected monthly from animal-baited traps close to flooded rice fields in two barangays (villages) in the Municipality of San Jose, Tarlac Province in Luzon, from May 2009 to July 2010. Virus was detected by nested reverse transcription PCR. Phylogenetic analysis of the amplified virus envelope gene was done using the maximum-likelihood method. A total of 28 700 known vector mosquitoes were collected, namely Culex vishnui, Culex fuscocephala, Culex tritaeniorhynchus, and Culex gelidus. JEV genotype III was detected in C. tritaeniorhynchus, belonging to the same genotype but form a different clade from those reported in the 1980s and in 2020 in this country. Japanese encephalitis is associated with rice cultivation and the presence of infected mosquitoes in Tarlac, Philippines. It remains to be seen whether the observed genetic shift of genotype III to genotype I in Asia will in time have an impact on the epidemiology of Japanese encephalitis in the Philippines. For long-term disease control, regular surveillance and Japanese encephalitis immunization in children and travelers in high risk areas are recommended.

1 February 2020 in Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
Verified
Journal Article
Open access
YSYusuke Sayama
Yusuke Sayama
MSMasato Sano
Masato Sano
MKMika K. Kaneko
Mika K. Kaneko
Yukinari KatoYukinari Kato
Yukinari Kato
Podoplanin (PDPN) is a small mucin-type transmembrane glycoprotein, which was first discovered in podocytes of the kidney. PDPN is a specific lymphatic endothelial marker and is also known as T1alpha, a marker of lung type I alveolar cells, or Aggrus, a platelet aggregation-inducing factor. PDPN possesses three platelet aggregation-stimulating (PLAG) domains and PLAG-like domains (PLDs), which bind to C-type lectin-like receptor-2. Previously, we developed a novel anti-whale PDPN (wPDPN) monoclonal antibody (mAb) PMab-237 using the Cell-Based Immunization and Screening (CBIS) method and the RIEDL tag of Arg-Ile-Glu-Asp-Leu sequence. PMab-237 detected wPDPN by flow cytometry, western blot, and immunohistochemical analyses. However, the specific binding epitope of PMab-237 for wPDPN remains unknown. In this study, deletion mutants and point mutants of wPDPN with N-terminal RIEDL tag were produced to analyze the PMab-237 epitope using flow cytometry. The analysis of deletion mutants showed that the N-terminus of the PMab-237 epitope exists between the 80th amino acid (AA) and the 85th AA of wPDPN. In addition, the analysis of point mutants demonstrated that the critical epitope of PMab-237 includes Leu82 and Thr84 of wPDPN, indicating that the PMab-237 epitope is located in the PLD of wPDPN.

18 June 2024 in Influenza and Other Respiratory Viruses
Verified
Journal Article
Open access
YSYusuke Sayama
Yusuke Sayama
ASAkie Sakagami
Akie Sakagami
MOMichiko Okamoto
Michiko Okamoto
MSMasahiro Sakamoto
Masahiro Sakamoto
HKHikari Koizumi
Hikari Koizumi
HOHitoshi Oshitani
Hitoshi Oshitani
Background: Viral recombination that occurs by exchanging genetic materials between two viral genomes coinfecting the same host cells is associated with the emergence of new viruses with different virulence. Herein, we detected a patient coinfected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) Delta and Omicron variants and identified various recombinants in the SARS‐CoV‐2 full‐length spike gene using long‐read and Sanger sequencing.Methods: Samples from five patients in Japan with household transmission of coronavirus disease 2019 (COVID‐19) were analyzed using molecular assays for detection and identification of SARS‐CoV‐2. Whole‐genome sequencing was conducted using multiplex PCR with short‐read sequencing.Results: Among the five SARS‐CoV‐2‐positive patients, the mutation‐specific assay identified the Delta variant in three, the Omicron variant in one, and an undetermined in one. The undermined patient was identified as Delta using whole‐genome sequencing, but samples showed a mixed population of Delta and Omicron variants. This patient was analyzed for viral quasispecies by long‐read and Sanger sequencing using a full‐length spike gene amplicon. In addition to the Delta and Omicron sequences, the viral quasispecies analysis identified nine different genetic recombinant sequences with various breakpoints between Delta and Omicron sequences. The nine detected recombinant sequences in the spike gene showed over 99% identity with viruses that were detected during the Delta and Omicron cocirculation period from the United States and Europe.Conclusions: This study demonstrates that patients coinfected with different SARS‐CoV‐2 variants can generate various viral recombinants and that various recombinant viruses may be produced during the cocirculation of different variants.

20 July 2023 in Clinical Infectious Diseases
Verified
Journal Article
Open access
PDF file
YSYusuke Sayama
Yusuke Sayama
MOMichiko Okamoto
Michiko Okamoto
MSMayuko Saito
Mayuko Saito
RTRaita Tamaki
Raita Tamaki
MSMariko Saito-Obata
Mariko Saito-Obata
HOHitoshi Oshitani
Hitoshi Oshitani
To the Editor—We read with interest the recently published study by Vlasova et al demonstrating a novel canine coronavirus (CoV) isolated from children hospitalized with pneumonia during 2017–2018 in East Malaysia [ 1]. The viruses of the family Coronaviridae infect avian species and various mammals [ 2]. Among the CoVs that infect humans (HCoVs), HCoV-229E, HCoV-NL63, HCoV-HKU1, and HCoV-OC43 usually cause mild symptoms [ 3]. However, in the past 2 decades, we have experienced the emergence of 3 highly pathogenic CoV species, namely, severe acute respiratory syndrome (SARS)-CoV, Middle East respiratory syndrome (MERS)-CoV, and SARS-CoV-2; all of these species are considered to have a zoonotic origin [ 4]. Therefore, it is crucial to know whether zoonotic CoV species are circulating in humans, especially in areas with similar environments to East Malaysia. Thus, we examined specimens collected to detect the CoV species, including zoonotic CoV from children admitted to 2 hospitals covering rural areas in the Philippines.

20 December 2024 in IJID Regions
Verified
Journal Article
Open access
CYChuyao Yu
Chuyao Yu
MCMaria Carmen A. Corpuz
Maria Carmen A. Corpuz
JBJoseph M. Bonifacio
Joseph M. Bonifacio
MKMakiko Kishi
Makiko Kishi
TITakeaki Imamura
Takeaki Imamura
MSMayuko Saito
Mayuko Saito
This study aimed to estimate the incidence of norovirus (NoV)-associated diarrhea and asymptomatic infections in children under 4 years of age and identify the genotypes of multiple NoV infections. A community-based cohort study was conducted in Tarlac, Philippines. Children aged 0-2 years were followed up for 2 years. The prevalence and incidence rates of NoV-associated diarrhea and asymptomatic infections were calculated. Risk factors were assessed using the Cox proportional hazards model. The genotypes and immunotypes of repeated infections were tabulated. A total of 338 children aged 6208 child-months were analyzed. NoV was detected in 17.4% (84 of 527, 95% confidence interval [CI]: 12.7-19.7%) of diarrheal episodes and 10.8% (219 of 2031, 95% CI: 9.4-12.3%) of asymptomatic stool samples. The highest incidence of NoV-associated diarrhea occurred in children aged 6-11 months (2.31 per 100 child-months, 95% CI: 1.30-3.32) and 18-23 months (2.34 per 100 child-months, 95% CI: 1.57-3.12), whereas the highest incidence of asymptomatic NoV infection was observed in children aged 12-23 months (4.49 per 100 child-months, 95% CI: 3.41-5.56). Repeated NoV infections were detected between different genotypes, except in two children who had repeated NoV GI.3 and two children with GI.9 infections. Children had the highest risk of NoV-associated diarrhea during their first year of life, whereas asymptomatic NoV infections persisted after the second year. Repeated NoV infections suggest genotype-specific immunity after NoV infection.